Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
Surgery|January 17, 2021
Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomyJonathan J Hue, Kavin Sugumar, Sarah C Markt, et al.Journal of Surgical Oncology|January 5, 2021
A comparison of surgical resection and liver transplantation in the treatment of intrahepatic cholangiocarcinoma in the era of modern chemotherapy: An analysis of the National Cancer DatabaseJonathan J Hue, Flavio G Rocha, John B Ammori, et al.American Journal of Surgery|March 19, 2026
Who bears the burden? Provider perspectives on barriers to gastrointestinal cancer careTrisha Lal, Anand Kathardekar, Christine Horvat-Davey, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 10, 2022
Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysisKavin Sugumar, Alex Hurtado, Ilora Naik, et al.Annals of Surgical Oncology|April 12, 2023
Understanding Factors Leading to Surgical Attrition for "Resectable" Gastric CancerHanna H Kakish, Fasih Ali Ahmed, Evonne Pei, et al.Annals of Surgical Oncology|July 22, 2024
The Utility of Sentinel Lymph Node Biopsy in Elderly Patients with MelanomaHanna Kakish, Carmen A Jung, Susan J Doh, et al.Case Reports in Oncological Medicine|December 31, 2025
Myocarditis Mimicking Takotsubo Cardiomyopathy With First Dose of Neoadjuvant Nivolumab-RelatlimabRohit Rao, Felicia Tejawinata, Tejasi Sachdeva, et al.Annals of Surgical Oncology|August 25, 2023
Trends in and Prognostic Significance of Time to Treatment in Pancreatic Cancer: A Population-Based StudyKavin Sugumar, Jonathan J Hue, Shreya Gupta, et al.Cancer Reports (Hoboken, N.J.)|July 10, 2021
The importance of time-to-adjuvant treatment on survival with pancreatic cancer: A systematic review and meta-analysisKavin Sugumar, Jonathan J Hue, Solanus De La Serna, et al.Journal of Pancreatic Cancer|May 3, 2021
Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic CancerJonathan J Hue, Katherine Bingmer, Kavin Sugumar, et al.Pageof 10